Riskpilot← Back to searchSign inGet full accessTherim Diagnostica AB
ABActiveOrg 5565862421Domkyrkovägen 23Research and experimental development on natural sciences and engineering · NACE 7210Est. 20000 employees
Revenue 2024
SEK 0
EBITDA margin
—
-117% vs 2023
Equity ratio
36.4%
Financial strength
Net profit 2024
SEK -22K
+87% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -22K | -117% |
| Net profit | SEK -22K | +87% |
| Total assets | SEK 754K | +64% |
| Equity | SEK 275K | -7% |
| Employees | 0 | — |
Legal name
Therim Diagnostica AB
Org number
5565862421
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
24 februari 2000
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva utveckling, vidareutveckla metoder för prediktion och monitorering inom det medicinska området ävensom idka därmed förenlig verksamhet.
Address
Domkyrkovägen 23
Email
canimguide@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −56 | −138 | −47 | 126 | −22 |
| Depreciation & amort. | −0 | −0 | −1 | −1 | −1 |
| EBIT | −56 | −138 | −48 | 125 | −23 |
| Net financials | — | 234 | 0 | −281 | 0 |
| Profit before tax | −56 | 95 | −48 | −156 | −22 |
| Tax | −0 | −4 | — | −16 | — |
| Net profit | −56 | 91 | −48 | −172 | −22 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 356 | 448 | 504 | 460 | 754 |
| Equity | 325 | 416 | 468 | 297 | 275 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 31 | 31 | 35 | 163 | 480 |
| Total debt | 31 | 31 | 35 | 163 | 480 |
EBITDA margin
-2155500.0%
This company
15.8%
Market median
-13642505% vs market
20202024
Equity ratio
36.4%
This company
38.2%
Market median
+5% vs market
20202024
Return on equity
-8.1%
This company
18.4%
Market median
-144% vs market
20202024
Net profit margin
-2219500.0%
This company
8.1%
Market median
-27401335% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.75×
This company
0.62×
Market median
-182% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
ET | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Therim Diagnostica AB 
Therim Research ABBoard members of Therim Diagnostica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Torsten Helge Wänström | Audit | 0 companies |
| Annika Charlotte Håkansson | Deputy Board Member | 0 companies |
| Leif Gunnar Håkansson | Board of Directors | 0 companies |